Found 0 matching trials
A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC PHASE2 This is an open-label, single-arm, prospective phase 2 study, evaluating th...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer PHASE2 This is an open-label, multi-center phase II clinical study consisting of t...
Show More Location
Zhongshan Hospital Affiliated to Fudan University
Learn More & Join Trial
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study PHASE2 This study will evaluate the efficacy and safety of irinotecan liposome(II)...
Show More Location
The Second Affiliated Hospital of Dalian Medical University
Learn More & Join Trial
Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial PHASE2 This study is a prospective, single arm phase II clinical trial ,aimed at e...
Show More Location
Multiple Locations
Learn More & Join Trial
Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 This trial aims to study the role of Ivonescimab combined with chemoradioth...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer PHASE2 Primary Objectives: Evaluate the complete response rate (CR rate) and safet...
Show More Location
Zhejiang cancer hosptial
Learn More & Join Trial
OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS) PHASE2 The efficacy of OVV-01 injection in combination with AK112 injection in sub...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors PHASE1 This study was designed to evaluate the efficacy and safety of YL201 in com...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
OVV-01 Intravenous and Intratumoral Injection Combined With AK112 for the Treatment of Advanced Solid Tumors PHASE1 This study is an open-label, multiple-route-of-administration dose-escalati...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma PHASE2 Study Overview
The primary objective of this clinical trial is to evaluate...
Show More Location
Department of Cancer Medical Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Learn More & Join Trial